Literature DB >> 6381540

High concentrations of antibodies to xanthine oxidase in human and animal sera. Molecular characterization.

G Bruder, E D Jarasch, H W Heid.   

Abstract

The widespread occurrence of antibodies (IgG) specific to xanthine oxidase in both normal (nonimmune) human and animal sera, and in antisera raised against a diversity of unrelated antigens is described. A study of sera from 81 humans revealed that xanthine oxidase-specific IgG represents a high proportion (1-8%) of total IgG. No obvious correlation to pathological events or symptoms of disease could be found. These xanthine oxidase-specific antibodies could be isolated by immunoaffinity chromatography on purified human or bovine xanthine oxidase and showed specific binding to the enzyme polypeptide of Mr 155,000 in immunoblotting experiments. By immunofluorescence microscopy they displayed the same cell type-specific reaction as experimentally induced antibodies, i.e., the staining of lactating mammary gland epithelium and capillary endothelium. The naturally occurring xanthine oxidase-specific antibodies consisted of polyclonal IgG of various subclasses. F(ab')2 preparations gave immune-reactions identical to those of IgG. The human xanthine oxidase-specific IgG cross-reacted with the bovine enzyme and both human and animal antibodies partially inhibited its activity. The xanthine oxidase activity of human milk lipid globules and supernatant fractions from various human tissues was extremely low when compared with that of the bovine antigen. The enzyme protein, however, was effectively precipitated from these sources by both the human and bovine antibodies. We suggest that the exceptionally high concentrations of antibodies against one protein, xanthine oxidase, are due to self-immunization to the xanthine oxidase antigen present in endothelial cells of capillaries. We do not exclude, however, nutritional contributions of bovine milk antigen to the appearance of xanthine oxidase antibodies in human sera. The possible biological functions of this immunological reaction are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381540      PMCID: PMC425232          DOI: 10.1172/JCI111494

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Endothelial cells and the biology of factor VIII.

Authors:  E A Jaffe
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Redox constituents in milk fat globule membranes and rough endoplasmic reticulum from lactating mammary gland.

Authors:  E D Jarasch; G Bruder; T W Keenan; W W Franke
Journal:  J Cell Biol       Date:  1977-04       Impact factor: 10.539

4.  Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization.

Authors:  B Guilbert; G Dighiero; S Avrameas
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

5.  Naturally occurring antibodies against nine common antigens in humans sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies.

Authors:  G Dighiero; B Guilbert; S Avrameas
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

6.  Naturally occurring autoantibodies to skeletal proteins from human red blood cells.

Authors:  H U Lutz; G Wipf
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

7.  Characteristics of membrane-bound and soluble forms of xanthine oxidase from milk and endothelial cells of capillaries.

Authors:  G Bruder; H Heid; E D Jarasch; T W Keenan; I H Mather
Journal:  Biochim Biophys Acta       Date:  1982-03-04

8.  C3c-binding ELISA for the detection of immunoconglutinins and immunoglobulin aggregates.

Authors:  A Hautanen; E Linder
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

9.  Human monoclonal IgM with autoantibody activity against intermediate filaments.

Authors:  K Dellagi; J C Brouet; J Perreau; D Paulin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Immunoglobulin M autoantibody to vimentin intermediate filaments.

Authors:  J L Senecal; N F Rothfield; J M Oliver
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

View more
  7 in total

1.  The role of human xanthine oxidoreductase (HXOR), anti-HXOR antibodies, and microorganisms in synovial fluid of patients with joint inflammation.

Authors:  Najah Al-Muhtaseb; Elham Al-Kaissi; Abdul Jalil Thawaini; Zuhair Muhi Eldeen; Sabah Al-Muhtaseb; Badiee Al-Saleh
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

2.  Prolonged fasting increases purine recycling in post-weaned northern elephant seals.

Authors:  José Guadalupe Soñanez-Organis; José Pablo Vázquez-Medina; Tania Zenteno-Savín; Andres Aguilar; Daniel E Crocker; Rudy M Ortiz
Journal:  J Exp Biol       Date:  2012-05-01       Impact factor: 3.312

Review 3.  A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase.

Authors:  A Kooij
Journal:  Histochem J       Date:  1994-12

4.  Allopurinol and reperfusion-induced arrhythmias: increased protection by simultaneous administration of anti-oxidant enzymes.

Authors:  R Crome; A S Manning
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

5.  Identification and isolation of soluble histones from bovine milk and serum.

Authors:  S Waga; E M Tan; R L Rubin
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

Review 6.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

Review 7.  Antioxidant and anti-inflammatory effects of exercise in diabetic patients.

Authors:  Saeid Golbidi; Mohammad Badran; Ismail Laher
Journal:  Exp Diabetes Res       Date:  2011-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.